1. Clinical Overview
A fixed-dose combination (FDC) therapy for moderate to severe Alzheimer's disease. Donepezil is a centrally acting, reversible acetylcholinesterase inhibitor, while Memantine is a low-affinity, voltage-dependent, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor. This combination provides dual neurochemical modulation, addressing both cholinergic deficit and glutamatergic excitotoxicity, which are key pathological features of Alzheimer's disease. It is a cornerstone of symptomatic management in the Indian context, aiming to improve cognition, function, and behavior.
| Onset | Duration | Bioavailability |
|---|---|---|
| Donepezil: Cognitive effects may be observed within 4-6 weeks. Memantine: Clinical effects typically seen within 4-12 weeks of treatment. | Donepezil: Approximately 24 hours (allows once-daily dosing). Memantine: Approximately 24-48 hours (allows once-daily dosing). | Donepezil: ~100%. Memantine: ~100%. |
2. Mechanism of Action
The combination exerts a synergistic effect by targeting two distinct pathological pathways in Alzheimer's disease. Donepezil increases acetylcholine concentration in the synaptic cleft by inhibiting its breakdown, thereby enhancing cholinergic neurotransmission, which is crucial for memory and learning. Memantine modulates glutamatergic transmission by blocking NMDA receptors, preventing pathological, chronic calcium influx into neurons (excitotoxicity) while allowing physiological, transient activation required for normal synaptic plasticity.
3. Indications & Uses
- Moderate to Severe Alzheimer's Disease (as per DSM-V or NINCDS-ADRDA criteria)
- Symptomatic treatment of dementia of the Alzheimer's type
4. Dosage & Administration
Adult Dosage: One tablet (Donepezil 5mg + Memantine 10mg) orally once daily, preferably at bedtime. For initiation in patients new to memantine, a titration schedule is recommended (start with memantine 5mg alone, then increase to 10mg, then switch to this FDC).
Administration: Administer orally, with or without food. Swallow whole with a glass of water. Bedtime administration may improve tolerability of initial cholinergic side effects (like nausea, diarrhea). Do not crush or chew. If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose.
5. Side Effects
Common side effects may include:
- Nausea
- Diarrhea
- Headache
- Dizziness
- Constipation (Memantine effect)
- Vomiting
- Fatigue
- Anorexia
- Muscle cramps
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Ketoconazole, Itraconazole, Erythromycin | Inhibit CYP3A4, increasing Donepezil plasma levels, risk of toxicity. | Major |
| Rifampicin, Carbamazepine, Phenytoin | Induce CYP3A4, decreasing Donepezil plasma levels, reducing efficacy. | Major |
| Paroxetine, Fluoxetine (Strong CYP2D6 inhibitors) | Increase Donepezil plasma levels. | Moderate |
| Cholinergic agents (Bethanechol, Pilocarpine) | Additive cholinergic effects, risk of syncope, bradycardia. | Major |
| Anticholinergic agents (Oxybutynin, Tolterodine, Tricyclic Antidepressants) | Antagonize Donepezil's therapeutic effect. | Moderate |
| Succinylcholine, similar neuromuscular blocking agents | Donepezil may prolong muscle paralysis. | Major |
| Hydrochlorothiazide, Cimetidine, Ranitidine, Quinidine | Alkalinize urine, reducing renal excretion of Memantine, increasing levels. | Moderate |
| Other NMDA antagonists (Amantadine, Dextromethorphan, Ketamine) | Additive CNS effects, risk of psychosis, confusion. | Major |
| Beta-blockers, Digoxin, Diltiazem, Verapamil | Increased risk of bradycardia and heart block with Donepezil. | Major |
7. Patient Counselling
- DO take the medicine exactly as prescribed, at the same time each day (preferably bedtime).
- DO inform all your doctors (including dentists) that you are taking this medicine.
- DO ensure adequate hydration.
- DO keep a symptom diary to track cognitive and behavioral changes.
- DONT stop taking the medicine suddenly without consulting your doctor.
- DONT double the dose if you miss one. Skip it and take the next at the regular time.
- DONT take over-the-counter cold, cough, or allergy medicines without checking with your pharmacist/doctor (may contain anticholinergics or dextromethorphan).
- DONT consume alcohol while on this medication.
8. Toxicology & Storage
Overdose: Cholinergic crisis (Donepezil predominance): Severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, respiratory depression, muscle weakness, seizures, loss of consciousness. Memantine predominance: CNS symptoms like psychosis, hallucinations, agitation, sedation, stupor, coma. Mixed: Combination of the above.
Storage: Store at room temperature (15-30°C). Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach of children and pets. Do not use after the expiry date printed on the pack.